INBX Inhibrx Biosciences, Inc.
8-K Current Report
Filed: February 23, 2026
Health Care
Biological Products, (No Diagnostic Substances)Inhibrx Biosciences, Inc. (INBX) 8-K current report filed with SEC EDGAR on February 23, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 7.01: Regulation FD Disclosure
AI Filing Analysis8-K
Item 7.01 · Regulation FD Disclosure
- • Updated corporate presentation posted Feb 23, 2026 to investor relations website and filed as Exhibit 99.1
- • Presentation used for investor conferences/meetings — signals active investor outreach, likely contains pipeline or strategic updates
Other Inhibrx Biosciences, Inc. 8-K Filings
Get deeper insights on Inhibrx Biosciences, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.